Clinical Trial: Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07640139) titled 'Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes' on June 03.

Brief Summary: The goal of this observational study is to identify the impact of incretin-based obesity medications (e.g., GLP-1 and GLP-1/GIP) on health and economic outcomes among adults who get their health insurance through their employers. The main questions it aims to answer are:

1. Is obesity medication usage is associated with reduced body mass index (BMI) and weight?

2. Is obesity medication usage is associated with reduced utilization of emergency department and inpatient care or obesity-related conditions over time?

3. Is obesit...